降低PLK1调节通过抑制ERK1/2通路来减轻ET-1诱导的心肌细胞缩
Jie Ding1, Anqi Yang1, Liping Zhou1
1Department of Cardiology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China.
Journal of cardiovascular translational research
|March 17, 2025
概括
波罗样酶1 (PLK1) 驱动心肌细胞缩,这是心力衰竭发展的关键因素. 抑制PLK1减少心脏细胞扩大和标记物,为心脏病提供潜在的治疗策略.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 心肌细胞缩是心力衰竭的重要危险因素.
- 基础心肌细胞缩的精确分子机制仍然不完全理解.
研究的目的:
- 研究波罗样酶1 (PLK1) 在内甲素-1 (ET-1) 诱导的心肌细胞缩中的作用.
- 阐明参与PLK1-介导心脏缩的分子途径.
主要方法:
- 评估了PLK1在缩性心肌细胞和心脏组织中的表达.
- 利用Plk1倒置和PLK1抑制剂 (BI2536) 来评估对心肌细胞大小和缩标志物 (ANP,BNP,β-MHC) 的影响.
- 研究了ERK1/2信号通路的参与,并测试了人类诱导的多能干细胞衍生心肌细胞 (hiPSC-CMs) 中的PLK1缺乏.
主要成果:
- 在ET-1引起的心脏缩和压力过载引起的心脏缩中,PLK1的表达显著增加.
- 降低PLK1和抑制PLK1降低了心肌细胞大小和抑制了缩标志物的表达.
- 确定ERK1/2通路是PLK1影响的关键下游调解器.
- 在hiPSC-CMs中,PLK1缺乏减弱的过度缩.
结论:
- PLK1在调节ET-1诱导的心肌细胞缩方面发挥着至关重要的作用.
- 在ERK1/2通道中介于PLK1.1.的高效应.
- PLK1代表了病理性心脏缩的潜在治疗标.
相关概念视频
cAMP-dependent Protein Kinase Pathways
6.1K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.1K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
GPCR Desensitization
5.7K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.7K


